Prostate Cancer: CME Event
“Prostate connection Irpinia-Sannio”, this is the title of the event, organized by EP Congressi with the unconditional contribution of IPSEN, which will take place on Saturday, February 19, 2022 at UPMC Hillman Cancer Center Villa Maria. At the center of the discussion is the treatment of prostate cancer.
The scientific directors of the course are Prof. PierCarlo Gentile, Medical Director of UPMC Hillman Cancer Center San Pietro FBF (Rome) and Head of Radiotherapy at the San Pietro Fatebenefratelli Hospital (Rome), and Dr. Corrado Franzese, President of the Italian Society of Territorial Urology (SIUT). The event will be attended by industry experts, including Dr. Sara Allegretta, Medical Director of UPMC Hillman Cancer Center Villa Maria. The course, aimed at oncologists, urologists, radiotherapists and biologists, is valid for the issue of 4 ECM credits.
Prostate Cancer: Multidisciplinarity and Synergies Between Specialists
Prostate cancer is a topic of extreme interest for modern clinical uro-oncology. It is, in fact, one of the most commonly diagnosed neoplasms, constituting about 20% of all newly diagnosed cancers. Most people with prostate disorders turn to urology clinics in the area, where there is often no possibility to perform second-level diagnostic tests and the connection with the reference centers, such as to allow the patient to continue his diagnostic therapeutic process. The multidisciplinary approach of this pathology is the key to therapeutic success. In fact, it guarantees patients the opportunity to take advantage of increasingly effective, tolerable and personalized therapeutic solutions, integrating technological advances in the surgical, oncological and radiotherapy fields.
Treatment options for treating prostate cancer include:
- surgery (standard/robotics)
- drug therapy (hormone therapy and/or chemotherapy)
- radiation therapy
Choices and combinations are made and personalized in relation to the patient.
Objectives of the Course
Therefore, the aim of this course is to expand the opportunities for meeting and discussion between specialists in the different disciplines who, inevitably, are faced with the same pathology and sometimes the same patient, with different approaches. It is therefore essential that specialists cooperate in order to optimize the treatment and subsequent follow-up of this pathology. With this aim, a closer collaboration has been created between the urologists who work in the provinces of Avellino and Benevento and the oncologists responsible for the Fatebenefratelli Sacro di Gesù hospital in Benevento, the Giuseppe Moscati Hospital in Avellino and the San Pio Hospital in Benevento.
In addition, the event will analyze the role of systemic therapies based on the use of anti-androgen drugs that have shown efficacy in the most advanced stages of the disease and the identification of the most suitable candidate for such treatments.